Public offering nets $70.5mm for Epizyme

15:40 EDT 4 Oct 2018 | Elsevier Business Intelligence

Epizyme Inc. (epigenetic medicines for cancer and other serious diseases) netted $70.5mm through the public sale of 8.3mm com...

Original Article: Public offering nets $70.5mm for Epizyme

More From BioPortfolio on "Public offering nets $70.5mm for Epizyme"